首页 › 超重 › 阿拉巴马州 › Birmingham
Birmingham AL 超重临床试验
16项针对 超重的研究正在 Birmingham及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
招募中3 期
- Univ of Alabama Birmingham, Birmingham
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
招募中3 期
- Univ of Alabama Birmingham, Birmingham
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
招募中2 期
- University of Alabama - Birmingham, Birmingham
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
招募中3 期
- Central Research Associates, Birmingham
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
招募中3 期
- Birmingham Clinical Research, Birmingham
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
招募中3 期
- Birmingham Clinical Research, Birmingham
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
招募中3 期
- AURORA-2 Clinical Site, Birmingham
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
招募中3 期
- AURORA-1 Clinical Site, Birmingham
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
招募中3 期
- Alabama Clinical Therapeutics, Birmingham
- University of Alabama at Birmingham, Birmingham
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
招募中3 期欢迎健康志愿者
- ACCOMPLISH-2 Research Site, Birmingham
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
招募中3 期
- Uni of Alabama at Birmingham, Birmingham
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
招募中3 期
- Kailera Clinical Site, Birmingham
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
招募中3 期
- ACCOMPLISH-1 Research Site, Birmingham
- ACCOMPLISH-1 Research Site, Birmingham
Time-restricted Eating for Postpartum Weight Loss
招募中
- University of Alabama at Birmingham, Birmingham
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
招募中
- University of Alabama at Birmingham, Birmingham
FELLAShip to Better Health
招募中
- The Worship Center Cristian Church, Birmingham
其他城市的 超重试验
- San Antonio, TX33 项研究
- Houston, TX33 项研究
- Chicago, IL28 项研究
- Orlando, FL25 项研究
- Miami, FL23 项研究
- Las Vegas, NV23 项研究
- Dallas, TX20 项研究
- Atlanta, GA20 项研究
- New York City, NY19 项研究
- Jacksonville, FL19 项研究
- Washington, DC19 项研究
- Austin, TX18 项研究
Birmingham的其他研究
- 癌症（所有类型）31 项研究
- 乳腺癌24 项研究
- 肥胖症23 项研究
- 卵巢癌23 项研究
- 非小细胞肺癌22 项研究
- 急性髓系白血病21 项研究
- 多发性骨髓瘤18 项研究
- 心血管疾病17 项研究
- 慢性阻塞性肺病17 项研究
- 囊性纤维化16 项研究
- 子宫内膜癌16 项研究
- 2型糖尿病16 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月1日。每项研究自行设定入选标准，由研究团队决定谁能参与。